期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

运动神经元病及运动神经元病综合征37例临床分析 被引量：1

下载PDF
导出
摘要 运动神经元病(MND)为选择性侵犯运动神经元的神经系统变性病,主要表现为骨骼肌萎缩、无力,直至呼吸肌麻痹而死亡.临床表现为MND而有明确病因者,称为运动神经元病综合征(MNDS).本文分析了1994年至2004年,我院37例MND及MNDS患者的临床资料,并探讨其病因及发病机制.
作者 许蕾 刘亚玲 郭艳苏 李春岩
机构地区 河北医科大学第二医院神经内科
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2005年第5期346-346,358,共2页 Chinese Journal of Nervous and Mental Diseases
关键词 运动神经元病综合征 临床分析 神经系统变性病 骨骼肌萎缩 呼吸肌麻痹 临床表现 临床资料 发病机制 MND
分类号 R744.8 [医药卫生—神经病学与精神病学] R971 [医药卫生—药品]
  • 相关文献

参考文献5

  • 1Ince PG, Evans J, knopp M ,et al. Corticalspinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology, 2003, 60 ( 8 ):1252.
  • 2Siklos L, Engelhardt J, Harati Y , et al. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol,1996,39(2) :203.
  • 3Cruz DC ,Nelson LM, McGuire V, et al. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis.Neuroepidemiology, 1999,18 ( 2 ): 101.
  • 4Mandrioli J,Faglioni P, Merelli E, et al. The epidemiology of ALS in Modena, Italy. Neurology ,2003,60 ( 4 ): 683.
  • 5姚晓黎,张为西,卢锡林,刘卫彬,张成.肌萎缩侧索硬化症患者血浆和脑脊液谷氨酸含量变化的研究[J].中国神经精神疾病杂志,2003,29(4):252-254. 被引量：6

二级参考文献13

  • 1Brooks BR. EI escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci, 1994, 124(suppl): 96.
  • 2Riviere M, Meininger V, Zeisser P, et al. An analysis of extended sunival in patients with amyotrophic lateral sclerosis created with riluzole.Arch Neural, 1998, 55(4): 526.
  • 3Favaron M, Manev H, Alho H, et al. Gangliosides prevent glutamate and kainate neurotoxicity in primary neuronal cultures of neonatal rat cerebellum and cortex. Proc Natl Acad Sci U S A, 1998, 85(19): 7351.
  • 4Debelleroche J, Recorgati A, Rose CF. Elevated levels of amino acids in the motor neuron disease patients. Neurochem Pathol, 1984, 2(1):1.
  • 5Rothstein JD, Kuncl R, Chaundhry V, et al. Excictatory amino acids in amyotrophic lateral sclerosis: an uplate. Ann Neural, 1991, 30(1): 224.
  • 6Shaw PJ, Forrest V, Ince PC,, et al. CSF and plasma amino acid level in motor neuron disease: elevation of CSF glutamate in a subest of patients.Neurodegeneration, 1995, 4(2): 209.
  • 7Niebroj DI, Janik P. Amino acids acting as transmitters in amyotrophic sclerosis. Acta Neurol Scand, 1999, 100( 1 ) : 6.
  • 8Patten BM, Harati Y, Acosta L, et al. Free amino acid levels in amyotrophic lateral sclerosis. Ann Neurol, 1978, 3(2): 305.
  • 9Perr TL, Krieger C, Hansen S, et al. Amyotrophic lateral sclerosis:amino acid levels in plasma and cerebrospinal fluid. Ann Neurol, 1990,28(1) : 12.
  • 10Camu W, Billiard M. Blady-Mouliner M. Fasting plasma and CSF amino acid level in amyotrophic lateral sclerosis: a subtype analysis. Acta Noarol Scand, 1993, 88(1): 51.

共引文献5

同被引文献18

  • 1Brooks BR,Miller RG , Swash M , et al. El Escoriol revisi-ted :Revised criteria for the diagnosis of amyotrophic lateralsclerosis. ALS Other Motor Neuron Disord,2000,1(5):293-299.
  • 2Mulder DW,Kurland LT , Offord KP , et al. Familial adultmotor neuron disease : amyotrophic lateral sclerosis. Neurolo-gy , 1986,36(4) : 511-517.
  • 3Logroscino G,Traynor BJ,Hardiman 0,et al. Descriptiveepidemiology of amyotrophic lateral sclerosis : new evidenceand unsolved issues. Neurol Neurosurg Psychiatry , 2008 , 79(1):6-11.
  • 4Gouveia L0,De CM . Young - onset sporadic amyotrophic lat-eral sclerosis : A distinct nosological entity . Amyotroph LateralScler, 2007 , 8(6) : 323-327.
  • 5Norris F,Shepherd R,Denys E,et al. Onset,natural his-tory and outcome in idiopathic adult motor neuron disease.Neurol Sci, 1993,118(1): 48-55.
  • 6Traynor BJ,Codd MB,Corr B,et al. Clinical features ofamyotrophic lateral sclerosis according to the El Escorial andAirlie House diagnostic criteria : A population - based study.Arch Neurol, 2000, 57(8) : 1171-1176.
  • 7Karam C,Scelsa SN,Macgowan DJ. The clinical course ofprogressive bulbar palsy. Amyotroph Lateral Scler,2010 , 11(4) ; 364-368.
  • 8Lee CN. Reviewing evidences on the management of patientswith motor neuron disease. Hong Kong Med J , 2012, 18(1 ) : 48-55.
  • 9D,amico E,Pasmantier M,Lee YW , et al. Clinical evolu-tion of pure upper motor neuron disease / dysfunction. MuscleNerve, 2012, 47 ( 1 ) : 28-32.
  • 10Wijesekera LC,Leigh PN. Amyotrophic lateral sclerosis . Or-phanet J Rare Dis,2009,4 : 3 .

引证文献1

二级引证文献12

中国神经精神疾病杂志
2005年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部